This course is designed to provide the learner with the most up to date knowledge of lead management in patients with implanted pacemaker and ICD devices. An in-depth review of indications for lead extraction and management of device infections will be presented, and the most up to date information on new techniques and technologies will be discussed. Approaches to minimize device related infections will be highlighted.  The program will feature multiple sessions with case based presentations and interactive panel discussions.

Lead Management Update 2023 Brochure (PDF)

Target Audience

Cardiologists, Cardiac Electrophysiologists, Cardiac Surgeons, Infectious Disease Specialists, Cardiac EP and Cardiology Fellows, Nurses, Lab Techs and Associated Professionals

REGISTRATION INFORMATION

Course Fee

$75 Physicians

$25 Nurses, Techs, and Fellows

Refunds

No refunds will be granted for this conference due to the low enrollment fee. A full refund will be provided if for any reason the course must be cancelled or rescheduled.

Questions

If you have questions about enrollment, please email ccpd@mednet.ucla.edu or call (310) 794-2620.

EXHIBITOR INFORMATION

Please email ccpd@mednet.ucla.edu.

OBJECTIVES

At the end of the conference, participants will be able to:

• Review the indications and techniques for lead extraction with Overview of the current ACC/AHA/HRS Lead Management guidelines
• Update the management of device complications including infections in 2023
• Provide the latest information and recommendations on the management of recalled leads
• Summarize current best practice to avoid device infections and lead complications

ACCREDITATION

The David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The David Geffen School of Medicine at UCLA, designates this live activity for a maximum of  7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California State Board of Registered Nursing accepts courses approved for the AMA PRA Category 1 Credits™ as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.

DISCLOSURES

The FDA has issued a concept paper that classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is “truly independent” and free of commercial influence. In addition to independence, the FDA requires that non-promotional, commercially supported education be objective, balanced and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program’s participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manage all identified potential conflicts of interest prior to the program. UCLA fully endorses the letter and spirit of these concepts.